These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26921685)

  • 1. The cyclophilin-inhibitor alisporivir stimulates antigen presentation thereby promoting antigen-specific CD8(+) T cell activation.
    Esser-Nobis K; Schmidt J; Nitschke K; Neumann-Haefelin C; Thimme R; Lohmann V
    J Hepatol; 2016 Jun; 64(6):1305-14. PubMed ID: 26921685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen production.
    Phillips S; Chokshi S; Chatterji U; Riva A; Bobardt M; Williams R; Gallay P; Naoumov NV
    Gastroenterology; 2015 Feb; 148(2):403-14.e7. PubMed ID: 25305505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cyclophilin inhibitor alisporivir prevents hepatitis C virus-mediated mitochondrial dysfunction.
    Quarato G; D'Aprile A; Gavillet B; Vuagniaux G; Moradpour D; Capitanio N; Piccoli C
    Hepatology; 2012 May; 55(5):1333-43. PubMed ID: 22135208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Hepatitis C Virus-Specific CD8 Effector T-Cell Function with Antiviral Effect in Infectious Hepatitis C Virus Coculture Model.
    Ojiro K; Qu X; Cho H; Park JJ; Vuidepot A; Lissin N; Molloy PE; Bennett A; Jakobsen BK; Kaplan DE; Riley JL; Chang KM
    J Virol; 2017 May; 91(10):. PubMed ID: 28275182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse Norovirus Infection Reduces the Surface Expression of Major Histocompatibility Complex Class I Proteins and Inhibits CD8
    Fritzlar S; Jegaskanda S; Aktepe TE; Prier JE; Holz LE; White PA; Mackenzie JM
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025).
    Softic L; Brillet R; Berry F; Ahnou N; Nevers Q; Morin-Dewaele M; Hamadat S; Bruscella P; Fourati S; Pawlotsky JM; Ahmed-Belkacem A
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32376613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
    Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
    J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alisporivir, a cyclosporin derivative that selectively inhibits cyclophilin, for the treatment of HCV infection.
    Watashi K
    Curr Opin Investig Drugs; 2010 Feb; 11(2):213-24. PubMed ID: 20112171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication.
    Ma-Lauer Y; Zheng Y; Malešević M; von Brunn B; Fischer G; von Brunn A
    Antiviral Res; 2020 Jan; 173():104620. PubMed ID: 31634494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine inhibits class II major histocompatibility antigen presentation by xenogeneic endothelial cells to human T lymphocytes by altering expression of the class II transcriptional activator gene.
    Charreau B; Coupel S; Boulday G; Soulillou JP
    Transplantation; 2000 Jul; 70(2):354-61. PubMed ID: 10933163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
    Van Gool SW; Zhang Y; Kasran A; de Boer M; Ceuppens JL
    Scand J Immunol; 1996 Jul; 44(1):21-9. PubMed ID: 8693288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells.
    Mangino G; Grazia Capri M; Barnaba V; Alberti S
    Int J Cancer; 2002 Oct; 101(4):353-9. PubMed ID: 12209960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN; Erdes E; Hebeisen M; Rufer N
    J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of MHC Class I Expression by Influenza A and B Viruses.
    Koutsakos M; McWilliam HEG; Aktepe TE; Fritzlar S; Illing PT; Mifsud NA; Purcell AW; Rockman S; Reading PC; Vivian JP; Rossjohn J; Brooks AG; Mackenzie JM; Mintern JD; Villadangos JA; Nguyen THO; Kedzierska K
    Front Immunol; 2019; 10():1158. PubMed ID: 31191533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells.
    Hengel H; Esslinger C; Pool J; Goulmy E; Koszinowski UH
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():2987-97. PubMed ID: 8847504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfates targeting increases MHC class I- and MHC class II-restricted antigen presentation and CD8(+) T-cell response.
    Knittel D; Gadzinski A; Hua S; Denizeau J; Savatier A; de la Rochère P; Boulain JC; Amigorena S; Piaggio E; Sedlik C; Léonetti M
    Vaccine; 2016 Jun; 34(27):3093-3101. PubMed ID: 27154391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir.
    Carbajo-Lozoya J; Ma-Lauer Y; Malešević M; Theuerkorn M; Kahlert V; Prell E; von Brunn B; Muth D; Baumert TF; Drosten C; Fischer G; von Brunn A
    Virus Res; 2014 May; 184():44-53. PubMed ID: 24566223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive Mutations in Replicase Transmembrane Subunits Can Counteract Inhibition of Equine Arteritis Virus RNA Synthesis by Cyclophilin Inhibitors.
    de Wilde AH; Boomaars-van der Zanden AL; de Jong AWM; Bárcena M; Snijder EJ; Posthuma CC
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8(+) T lymphocytes.
    Van Overtvelt L; Andrieu M; Verhasselt V; Connan F; Choppin J; Vercruysse V; Goldman M; Hosmalin A; Vray B
    Int Immunol; 2002 Oct; 14(10):1135-44. PubMed ID: 12356679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.